Gastric Cancer Disparities Initiative
About the GCDI
Gastric cancer is the third leading cause of cancer death worldwide and is diagnosed in 27,000 Americans each year. In the United States, this burden falls disproportionately on ethnic minorities and immigrant communities, especially Asians. There exists no coherent national strategy for the early detection or risk attenuation of gastric cancer, even among identified high-risk groups. As a result, patients with gastric cancer in the US are diagnosed at later stages and demonstrate worse overall survival compared to nations of East Asia with established screening programs.
The under-recognition of gastric cancer risk among minority communities may be one of the most significant unaddressed healthcare disparities in the United States. There is a need for a national dialogue on strategies to decrease morbidity and mortality from gastric cancer in the United States, especially among the most vulnerable populations.
Upcoming 2024 Gastric Cancer Summit
Join us for the 2024 Gastric Cancer Summit, taking place at Stanford University and virtually on November 7-8, 2024. This in-person summit will gather physicians, researchers, policy makers, patients, and advocacy groups from around the world to address the pressing issue of gastric cancer.
Hosted by the Stanford Center for Asian Health Research and Education (CARE), this multidisciplinary event will build upon the foundation laid in previous summits, working towards tangible solutions and a roadmap for addressing healthcare disparities in gastric cancer.
Together, we can improve early detection, prevention and healthcare outcomes for all affected by gastric cancer.